Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients-Reference-Cited by-同舟云学术

Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients

Published:2017-10-03 Issue:1 Volume:38 Page:141-147
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Haj Yahia Soad,Ben Zvi Ilan,Livneh Avi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/article/10.1007/s00296-017-3823-1/fulltext.html

Reference31 articles.

1. Almeida de Jesus A, Goldbach-Mansky R (2013) Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol 147:155–174

2. Touitou I, Koné-Paut I (2008) Autoinflammatory diseases. Best Pract Res Clin Rheumatol 22:811–829

3. Yang J, Xu H, Shao F (2014) Immunological function of familial Mediterranean fever disease protein pyrin. Sci China Life Sci 57:1156–1161

4. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G et al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644–651

5. Terkeltaub RA (2009) Colchicine update: 2008. Semin Arthritis Rheum 38:411–419

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of CYP1A1 Alleviates Colchicine-Induced Hepatotoxicity;Toxins;2024-01-09

2. A case report of colchicine toxicity progressing from diarrhea to rhabdomyolysis: The probable role of interaction with ciprofloxacin;International Journal of Rheumatic Diseases;2024-01

3. What is the lowest lethal dose of colchicine?;Biotechnology & Biotechnological Equipment;2023-11-25

4. Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib;Pharmacia;2023-10-20

5. CYP3A4/P-glycoprotein inhibitors related colchicine toxicity mimicking septic shock;BMJ Case Reports;2023-10